Strong quarter with Funded Loan Volume up 45%, Revenue up 41%, and Total Expenses flat in Q2’24 as compared to Q1’24 Continue leaning into growth opportunities and expect Q3’24 Funded Loan Volume of over $1 billion Positive early indications from investments in AI within the Tinman platform geared towards loan team productivity and customer experience
PLANO, Texas, July 15, 2024–(BUSINESS WIRE)–Finance of America Companies Inc. (“Finance of America” or the “Company”) (NYSE: FOA), a leading provider of home equity-based financing solutions for a modern retirement, today announced that it expects its intended 1-for-10 reverse stock split of its outstanding shares of Class A Common Stock, previously disclosed on June 27,
Checkpoint Therapeutics, Inc WALTHAM, Mass., May 10, 2024 (GLOBE NEWSWIRE) — Checkpoint Therapeutics, Inc. (“Checkpoint”) (Nasdaq: CKPT), a clinical-stage immunotherapy and targeted oncology company, today announced financial results for the first quarter ended March 31, 2024, and recent corporate updates. James F. Oliviero, President and Chief Executive Officer of Checkpoint, said, “Over the past few